InsiderTrades

Form 4 for PFE Pfizer

Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-26 · accession 0001225208-22-003664 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-01 2022-02-26 PFE Hwang Angela Group Pres M - OptEx $25.60 +12.7K 19.4K +190% +$325.5K
DM 2022-03-01 2022-02-26 PFE Hwang Angela Group Pres F - Tax $49.56 -9,398 15.9K -37% -$465.8K
D 2022-03-01 2022-02-26 PFE Hwang Angela Group Pres M - OptEx $0.00 -12.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-26 M A 12,716 $25.60 19,393 D — — (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
2 Common Common Stock 2022-02-26 F D 5,937 $50.64 9,995 D — — (F4) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F5) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
3 Common Common Stock 2022-02-26 F D 3,461 $47.72 15,932 D — — (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. (F3) Price is the closing price of Pfizer common stock on February 25, 2022.
4 Derivative Stock Appreciation Rights 2022-02-26 M D 12,716 $0.00 0 D $25.60 · 2022-02-26 to 2022-02-26 12,716 Common Stock